Moderna says the Food and Drug Administration needs more time to review its COVID-19 vaccine in teenagers. Moderna says the FDA wants to review the risk of heart inflammation in its vaccine in children and teens ages 12-17.
U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.
Federal regulators are expected to authorize the mixing and matching of COVID-19 booster doses this week in an effort to provide flexibility as the campaign for extra shots expands.
U.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
Vaccine advisors are set to discuss mixing and matching COVID-19 vaccines Friday.
With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it’s their turn.
White House officials have also announced a plan to offer a booster shots to fully vaccinated Americans who got the Pfizer or Moderna vaccine. They are citing new evidence of waning vaccine protection over time, but where does that leave the Johnson & Johnson vaccine when it comes to boosters?
Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.
Folks could get a free beer at River Rat Brewery today by getting vaccinated through DHEC’s “Shot and a Chaser” campaign.
Moderna Inc. has filed a request with the European Medicines Agency for its COVID-19 vaccine to be granted authorization for use in adolescents. Moderna has also filed for authorization to use its vaccine under emergency use regulations in the U.S. and Canada.
